Invention Grant
US09588122B2 Methods of treating cancer sensitive to anti-EGFR therapy and modifying treatment using peroxiredoxin 6 biomarker 有权
治疗对抗EGFR治疗敏感的癌症的方法和使用过氧氧化还原酶6生物标志物进行改良治疗

Methods of treating cancer sensitive to anti-EGFR therapy and modifying treatment using peroxiredoxin 6 biomarker
Abstract:
The present disclosure provides methods of treating cancer and modifying a cancer treatment for a cancer with an anti-EGFR drug by creating PRDX6 expression profiles and using the profiles to evaluate and optionally modify treatment. The present disclosure also provides assays and systems for assessing sensitivity of a cancer to an anti-EGFR therapy.
Information query
Patent Agency Ranking
0/0